Table 1. Normal reference range established for each individual probe for CLL MLPA.
Probe (gene/chromosome) | Normal range (Mean ± 2SD; 95% CI, P = 0.05)* | Normal range (Mean ± 3SD; 99% CI, P = 0.01)* |
PTEN1 10q23.3 | 0.84–1.16 | 0.76–1.24 |
PTEN2 10q23.3 | 0.89–1.11 | 0.84–1.16 |
ATM1 11q23 | 0.85–1.15 | 0.78–1.22 |
ATM2 11q23 | 0.87–1.13 | 0.80–1.20 |
ATM3 11q23 | 0.84–1.16 | 0.76–1.24 |
ATM4 11q23 | 0.88–1.12 | 0.82–1.18 |
RDX 11q23 | 0.91–1.09 | 0.86–1.15 |
CD27 12p13.31 | 0.82–1.18 | 0.73–1.27 |
APAF 12q23.1 | 0.86–1.14 | 0.83–1.17 |
IGF1 12q23 | 0.87–1.13 | 0.85–1.15 |
PAH1 12q23 | 0.89–1.11 | 0.83–1.17 |
PAH2 12q23 | 0.88–1.12 | 0.82–1.18 |
RB1 13q14.2 | 0.87–1.13 | 0.81–1.19 |
KCNRG 13q14.3 | 0.89–1.11 | 0.84–1.16 |
DLEU1 1 13q14.3 | 0.87–1.13 | 0.80–1.20 |
DLEU1 2 13q14.3 | 0.87–1.13 | 0.80–1.20 |
DLEU1 3 13q14.3 | 0.85–1.15 | 0.78–1.22 |
ATP7B 13q14.3 | 0.87–1.13 | 0.80–1.20 |
TP53 1 17p13.1 | 0.83–1.17 | 0.74–1.26 |
TP53 2 17p13.1 | 0.83–1.17 | 0.81–1.19 |
TP53 3 17p13.1 | 0.83–1.17 | 0.81–1.19 |
TP53 4 17p13.1 | 0.84–1.16 | 0.76–1.24 |
SMAD4 18q21.1 | 0.86–1.14 | 0.79–1.21 |
CDKN2D 19p13.2 | 0.86–1.14 | 0.80–1.20 |
LDLR 19p13.2 | 0.89–1.11 | 0.83–1.16 |
CCNE1 19q12 | 0.89–1.11 | 0.83–1.17 |
CHMP2 19q13.43 | 0.89–1.11 | 0.83–1.17 |
*Both 95% and 99% confidence interval corresponding to normal DNA content of all probes are presented. These data were based on 50 DNA samples of blood from healthy controls.